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Abstract Proteins exhibit a variety of motions ranging from
amino acid side-chain rotations to the motions of large domains.
Recognition of their conformational flexibility has led to the view
that protein molecules undergo fast dynamic interconversion
between different conformational substates. This proposal has
received support from a wide variety of experimental techniques
and from computer simulations of protein dynamics. More
recently, studies of the subunit dissociation of oligomeric proteins
induced by hydrostatic pressure have shown that the character-
istic times for subunit exchange between oligomers and for
interconversion between different conformations may be rather
slow (hours or days). In such cases, proteins cannot be treated as
an ensemble of rapidly interconverting conformational substates,
but rather as a persistently heterogeneous population of different
long-lived conformers. This is reminiscent of the deterministic
behavior exhibited by macroscopic bodies, and may have
important implications for our understanding of protein folding
and biological functions. Here, we propose that the deterministic
behavior of proteins may be closely related to the genesis of
conformational diseases, a class of pathological conditions that
includes transmissible spongiform encephalopathies, Alzheimer’s
disease and other amyloidosis. ß 2001 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Following the landmark studies of An¢nsen [1], protein
folding has generally been viewed as a process in which a
polypeptide chain performs a search in conformational space
to achieve the so-called ‘native’ conformation corresponding
to the global free-energy minimum under a given set of phys-
icochemical conditions of the medium. Given the vast size of
the conformational space available for folding of even the
smallest proteins [2], it was recognized early that folding did
not take place by random sampling of all accessible confor-
mations. Instead, the conformational search is currently
thought to take place in an energy landscape similar to a
multidimensional funnel, the slope of which e¡ectively guides
the protein down towards the energy minimum [3,4]. The
funnel therefore leads to a huge increase in folding rate (com-
pared to the expected rate for a random di¡usional process)
and prevents entrapment in partially folded states (local en-
ergy minima). Recent results, however, have shown that pro-
tein folding to a biologically competent conformation does
not always or necessarily lead to a unique state corresponding
to the overall free-energy minimum. In some cases, the exis-
tence of metastable conformations has been characterized,
indicating kinetic rather than thermodynamic control of the
folding process [5]. In other cases, folding appears to continue
even after the achievement of full biological function (i.e. a
slow annealing of the protein structure; [6,7]).
Furthermore, for oligomeric proteins folding is often mark-
edly dependent on protein^protein interactions. The equilibri-
um of subunit association is generally considered to result
from a large number of stochastic association^dissociation
events. As a result, the equilibrium is dependent on protein
concentration, as expected from the law of mass action. How-
ever, recent studies have shown deviations from this expected
behavior in the investigation of the equilibrium of subunit
association in oligomers ranging from dimers to viral par-
ticles. In those cases, an anomalous or complete lack of pro-
tein concentration dependence for subunit association was
found [8]. This results from high activation free-energy bar-
riers for subunit exchange between oligomers, which leads to
very slow rates of exchange during biologically relevant time-
scales [9,10]. As a result, a persistent (long-lived) conforma-
tional heterogeneity is generated in the protein ensemble. This
type of behavior has been described as deterministic [8,9] to
indicate the persistent heterogeneity or molecular individuality
of proteins.
In recent years, studies of protein folding and, in particular,
of misfolding and interactions have been stimulated by the
realization that misfolding and aggregation are involved in a
number of the so-called ‘conformational’ diseases, of which
transmissible spongiform encephalopathies and Alzheimer’s
disease (AD) are striking examples. The molecular/energetic
basis of protein misfolding and aggregation (leading to the
formation of amyloid aggregates) in conformational diseases
are still largely unknown. Understanding the molecular mech-
anisms of amyloid formation would represent an important
¢rst step in the development of rational strategies to interfere
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with aggregation and the resulting pathological conditions.
Here, we propose that kinetically controlled folding and de-
terministic behavior may be closely related to the generation
of amyloidogenic conformations of proteins.
2. Protein dynamics: hierarchical conformational substates,
folding funnels and metastable conformations
Proteins have long been known to be conformationally dy-
namic. Since the pioneering studies by Linderstro«m-Lang [11]
on the exchange of amide hydrogens of protein backbones
with hydrogens of the solvent water, multiple lines of evidence
have shown that proteins exhibit a wide range of motions over
several orders of magnitude in time. For example, NMR and
£uorescence studies of protein motions have provided connec-
tions between experimental results and predictions from mo-
lecular dynamics simulations (for early perspectives, see [12^
15]). Because peptide bond planes can undergo rotations of
tens of degrees with activation energies as low as a few kJ/
mol, protein motions are thought to occur in a relatively un-
impeded way, leading to fast interconversion rates between
di¡erent conformational states [16].
Studies carried out by Frauenfelder and co-workers have
been particularly revealing in characterizing the existence of
conformational substates in proteins. They showed that the
kinetics of re-binding of CO to myoglobin was markedly non-
exponential at low temperatures [17,18]. Non-exponential ki-
netics originates from the existence of several conformational
substates of myoglobin possessing distinct CO binding rates.
At room temperature, the rate of interconversion between
di¡erent conformational substates is fast, due to the low acti-
vation barriers between them. With decreasing temperatures,
the activation barriers become more di⁄cult to overcome,
leading to long-lived occupancy of di¡erent substates.
Using time-resolved £uorescence as a probe of protein con-
formational dynamics, we and other groups have shown that
proteins exhibit signi¢cant conformational heterogeneity at
room temperature (for early examples, see [19^22]). These
results indicate that the activation free-energy barriers for
interconversion between substates may be su⁄ciently high to
lead to the observation of conformational heterogeneity even
at room temperature. These studies further indicate that the
model of conformational substates discussed above is gener-
ally applicable to describe the dynamics of proteins.
During the past two decades, an impressive amount of in-
formation on the energetics, kinetics and pathways of folding
of several di¡erent proteins has been obtained. At the same
time, e¡orts have been made to incorporate experimental re-
sults into conceptual frameworks that could be generally ap-
plicable to describe folding. In this regard, the introduction of
the idea that proteins fold in a funnel-shaped energy land-
scape (Fig. 1) [3,4,17] appears particularly useful in explaining
some of the key issues of folding. However, the funnel model
generally considers that the end-point of folding corresponds
to a unique, native state corresponding to the global free-en-
ergy minimum of the system [4]. In light of the considerations
presented above, it would seem that including the possible
existence of multiple conformers at the bottom of the funnel
would be more appropriate.
For several proteins, the ¢nal outcomes of folding appear
to be determined by kinetic rather than thermodynamic fac-
tors (reviewed in [5]). These studies indicate that the free-en-
ergy barriers in conformational space can be quite high, lead-
ing to the persistence of metastable states. In such cases, the
¢nal folded state may not correspond to the global free-energy
minimum, and the free-energy diagram for folding may be
considerably more rugged or complicated than the funnel rep-
resented in Fig. 1. The existence of high activation barriers for
interconversion between conformational substates may pre-
vent the achievement of the most stable conformations of
proteins [5] or lead to the co-existence of long-lived conform-
ers that markedly di¡er in stability (see below). In either case,
di¡erences in biological function may also be expected from
di¡erent protein conformers.
3. Persistent conformational heterogeneity and deterministic
behavior of proteins
The reversible association of multiple subunits to form an
oligomeric protein is expected to obey the law of mass action,
being thus dependent on protein concentration. This is a con-
sequence of the fast exchange of subunits between oligomers,
leading to energetic/conformational averaging of all the mol-
ecules in the ensemble. However, investigation of the revers-
ible subunit dissociation of several oligomers by hydrostatic
pressure has revealed signi¢cant deviations from the law of
mass action [8,23^25]. This anomalous behavior ranges from
the reduced dependence on protein concentration for subunit
association/dissociation in trimers and tetramers [9,25] to a
complete lack of protein concentration dependence for the
association of large protein aggregates such as viral particles
[26,27]. This behavior has been investigated in detail in the
case of dimeric triosephosphate isomerase (TIM) [8,10]. The
dissociation of TIM subunits induced by hydrostatic pressure
was found to be completely independent of protein concen-
tration, in apparent violation of the law of mass action [8]. In
subsequent studies, the kinetics and equilibrium of dissocia-
tion/unfolding of TIM induced by guanidine hydrochloride
were investigated [10]. These studies showed that the activa-
Fig. 1. The protein folding funnel, showing the dependence of the
overall free energy of the protein on conformation. The diagram is
color-coded according to the con¢gurational entropy level of the
polypeptide chain (red for high entropy and blue for low entropy).
Folding proceeds from a disordered state to progressively more or-
dered conformations corresponding to lower energy levels. Possible
folding intermediates are represented by local energy minima. The
native state, at the bottom of the funnel, is thought to correspond
to a unique conformation (or a very homogeneous set of conforma-
tions in fast exchange).
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tion free-energy barriers for dissociation of TIM dimers are
quite high (v99 kJ/mol), corresponding to a characteristic
time of dissociation of 15 h or longer. As the refolding/reas-
sociation of TIM subunits were found to be fast [10], the
characteristic dissociation time is the rate-limiting step in a
cycle of dissociation/reassociation. This prevents the exchange
of TIM subunits between di¡erent dimers in times ranging
from several hours to days, preventing conformational/ener-
getic averaging of the molecules in the ensemble. In other
words, energetic/conformational di¡erences between individu-
al TIM dimers in solution may remain ‘frozen’ during bio-
logically relevant time-scales (hours to days). In line with this
hypothesis, di¡erent populations of TIM dimers exhibiting
persistent di¡erences in thermodynamic stability were found
in experiments in which dimer dissociation was induced by
hydrostatic pressure (Fig. 2) [8] or guanidine hydrochloride
(Moreau et al., in preparation). This led us to propose the
existence of persistent conformational heterogeneity to explain
the behavior of TIM. In practical terms, TIM dimers present
a certain degree of ‘molecular individuality’ and behave as a
deterministic system, in analogy with the behavior exhibited
by macroscopic objects.
The concepts of molecular individuality and deterministic
behavior of proteins may have profound implications in our
understanding of the relationships between stability and bio-
logical functions. Many biologically important processes such
as catalysis, metabolic protein turnover, viral infection and
replication, amyloid formation (see below) and many others
occur on time-scales that are comparable to or shorter than
the slow dynamics of conformational interconversion that
lead to deterministic behavior. This means that, under certain
circumstances, these biological processes may involve not ho-
mogeneous protein populations, but rather persistently heter-
ogeneous ensembles of conformations.
For example, for virus particles a clear need for a distribu-
tion of conformations that can be regarded as ‘frozen’ in time
was pointed out by Weber and co-workers [26,27]. A typical
virus shell consists of the non-covalent assembly of dozens of
copies of one or a few types of coat proteins. Therefore, the
assembly of the capsid should be sharply dependent on pro-
tein concentration. In an infected cell, the constituent virus
coat proteins are over-expressed, and it is thermodynamically
favorable to assemble a virus particle. However, after cell lysis
and release of the virus into the environment, the concentra-
tion of viral particles is so low that each virus can be consid-
ered a single, isolated particle. This means that the stochastic
chance of reassociation would be extremely small if a virus
particle dissociated under these conditions. Therefore, the rate
of subunit dissociation (i.e. capsid disassembly) has to be neg-
ligibly slow in order to assure the long-term survival of the
assembled virus. Thus, despite the fact that virus association is
thermodynamically unstable under these conditions, the viral
particle persists as a ‘frozen’ macromolecular species, rather
than as an assembly that is in dynamic chemical equilibrium
with its constituent monomers.
For enzymes such as TIM, a bene¢t that could result from
adopting a permanently folded structure (rather than under-
going cycles of dissociation/association) is an increase in re-
sistance to chemical modi¢cation such as thiol oxidation,
deamidation or proteolytic digestion [8]. Unfolded or unstruc-
tured conformations are in general more vulnerable to these
covalent modi¢cations. Indeed, the marked resistance of TIM
against oxidation and proteolysis is directly correlated with
maintenance of its native dimeric structure [8,28,29].
Perhaps one of the most interesting possible implications of
deterministic behavior and molecular individuality of proteins
is in relation to the genesis of conformational or amyloid
diseases, as discussed below.
4. The individuality of protein molecules and conformational
diseases
Conformational diseases comprise a class of important hu-
man pathologies including AD and Parkinson’s diseases and
the transmissible spongiform encephalopathies. It is believed
that these pathological conditions are related to conforma-
tional changes from non-toxic to toxic forms of speci¢c pro-
teins or fragments.
Transmissible spongiform encephalopathies (such as bovine
spongiform encephalopathy (BSE) in cattle and Creutzfeld^
Jakob disease (CJD) in humans) are associated with the ac-
cumulation in the brain of an abnormal protease-resistant
form of the prion protein (PrP). Mammalian prion diseases
are apparently transmitted directly by PrP and do not involve
genetic transmission via nucleic acids [30^32]. It is believed
that the disease is caused by a conformational change in
PrP from a benign cellular conformation (PrPC) to a neuro-
toxic form (PrPSc) that self-propagates by recruiting and in-
ducing the conformational change in additional PrPC mole-
cules.
The economic and public health impact of prion diseases
has stimulated substantial research into the biochemistry, cell
biology and epidemiology of prion toxicity. However, the mo-
lecular/energetic basis of prion transmission are still incom-
pletely understood. For example, little is known on the mo-
lecular state of the protein that corresponds to the infectious,
self-propagating particle. It is known that one infectious unit
corresponds to approximately 105 PrP molecules [33]. This
could mean that infection is caused by a large aggregate of
PrPSc molecules or, alternatively, that a single one of those
molecules is actually infectious.
A puzzling feature of the prion hypothesis regards the ex-
istence of prion ‘strains’, i.e. clinically distinct disease forms
within a single animal species that are not associated with
mutations in the PrP gene (e.g. eight di¡erent strains have
been reported that propagate in the hamster; [34]). Thus,
Fig. 2. Molecular individuality of TIM dimers. The scheme is based
on results from pressure-induced dissociation of TIM subunits [8].
At atmospheric pressure (1 bar), TIM exists as a heterogeneous en-
semble of strong (red) and weak (green) dimers with respect to their
pressure stability. Application of an intermediate pressure (2.4 kbar)
causes reversible subunit dissociation of the weak dimers only. De-
compression to atmospheric pressure causes subunit reassociation
and a second cycle of pressure (to 2.4 kbar) only brings about dis-
sociation of the weak dimers again. This indicates lack of conforma-
tional exchange between weak and strong dimers during the experi-
mental time-scale (i.e. several hours). Strong dimers can only be
dissociated at high pressure (3.5 kbar).
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di¡erent copies of the same gene product (with identical ami-
no acid sequences) appear to exist in di¡erent conformations.
These observations imply a persistent, long-lived conforma-
tional heterogeneity of prion molecules, which allows di¡erent
strains to be perpetuated over long periods of time and even
when passaged through an intermediate species with a di¡er-
ent PrP gene [35]. Such persistent conformational heterogene-
ity is reminiscent of the situation described above regarding
the energetic basis of the molecular individuality of proteins.
Thus, the origin of prion strains may reside in the existence of
multiple conformational substates of PrP separated by su⁄-
ciently high activation free-energy barriers. In this regard, a
recent study from Prusiner’s group described that di¡erent
strains of hamster prions exhibit di¡erent sensitivities to un-
folding by guanidine hydrochloride [34]. This is completely
analogous to the behavior we have described for TIM (see
above; [8]), and indicates the deterministic nature of prions.
Molecular modeling has also indicated that the octapeptide
repeat region located in the N-terminal domain of PrP is
capable of adopting several di¡erent conformations with iden-
tical stabilities upon binding copper ions [36]. Furthermore,
PrPC in solution appears to have a predominantly K-helical
fold [37^40], despite the fact that most of the amino acid
residues in PrP have a preference for L-conformation [36].
Thus, it is possible that PrP exists in a balance between the
native K-helical fold determined by the docking of side-chains
and the L-structure that would otherwise be preferred by
structural propensity [36]. High free-energy barriers, leading
to slow interconversion between them, likely separate these
two largely di¡erent conformations. Finally, NMR measure-
ments have shown that a loop between L-strand 2 and K-helix
2 in PrP exhibits relatively slow conformational £uctuations
(i.e. slower than the limits of detection by NMR) [40]. Inter-
estingly, this loop is also one of the regions of greater varia-
bility in charge distribution on the surface of PrP from di¡er-
ent species, suggesting that it may be involved in the species
barrier for transmission [40].
The hypothesis presented above of the deterministic behav-
ior of prions (and its relationship to strain formation) can be
considered in light of some of the known features of prion
biochemistry. In vitro, prions have been shown to form amy-
loid ¢brils [41,42]. In a persistently heterogeneous ensemble,
conceivably only a fraction of the molecules is in the ‘appro-
priate’ conformation for aggregation into ¢brils. Thus, the
initial rate of ¢bril formation is slow. After formation of a
certain amount of amyloid ‘seeds’, the speed of ¢brillization
increases, which has been interpreted as indicative of tem-
plate-induced conversion of additional PrP molecules. Alter-
natively, we propose that the seeds might select from the so-
lution those PrP molecules that already exhibit the
aggregation-prone conformation (Fig. 3). It is important to
note that both processes (template-induced polymerization
or selection of speci¢c molecules from the ensemble) would
give rise to the same type of kinetics of amyloid formation.
Thus, future investigation of the deterministic hypothesis will
probably require detailed characterization of the existence of
persistent conformational heterogeneity in the ensemble of
PrP molecules prior to amyloid aggregation.
Using the Sup35 yeast prion model, Chien and Weissman
[43] have recently proposed that the conformational diversity
of prion molecules is related to the species barrier for trans-
mission. They showed that a chimera containing the prion
domains of Sup35 from Candida albicans and Saccharomyces
cerevisiae could be seeded to form amyloid ¢brils using both
Sup35 ‘parental’ species. However, a species transmission bar-
rier prevented direct cross-seeding of C. albicans or S. cerevi-
siae prions. These results led them to propose that the chimera
was su⁄ciently £exible to undergo template-induced conver-
sion to either type of parental amyloid ¢bril (Fig. 3A). Similar
observations were made in the transmission of human prions
to mice expressing a chimera of mouse and human prions [44].
On the basis of the previous discussion, an alternative explan-
ation for these results is that the seeds select the speci¢c am-
yloidogenic PrP (or chimeric Sup35) conformations amongst
multiple conformations present in the ensemble (Fig. 3B).
5. Targeting the stability of amyloid ¢brils as a possible
strategy in amyloidosis
Insight into the energetics of amyloid ¢bril formation may
provide guidance to the development of strategies to interfere
with aggregation and to prevent amyloid-related toxicity.
In a recent study [45], we have investigated the stability of
amyloid ¢brils of the L-amyloid peptide (AL) involved in amy-
loid formation and deposition in senile plaques in the brains
of AD patients. AL plays a central role in the neuropathology
of AD [46^49]. Although recent studies have shown that non-
¢brillar AL may be involved in neurodegeneration, consider-
able evidence indicates that AL aggregation and amyloid dep-
osition are related to AD neurotoxicity ([50^52] and refs.
therein). Thus, agents capable of interfering with aggregation
have the potential to prevent or diminish the toxicity of AL.
In the lack of detailed molecular structures of either soluble
or ¢brillar AL (which precludes a structure-based drug design
approach), our strategy to identify potential anti-amyloido-
genic compounds initially relied on an investigation of the
stability of amyloid ¢brils. To this end, amyloid ¢brils formed
Fig. 3. Alternative hypothesis for prion strain formation. A: Shows
the ‘template-induced conformational change’ model (based on [43]).
The original population of chimeric prion molecules (red squares) is
believed to be homogeneous and su⁄ciently plastic to conform to
templates (‘seeds’) consisting of either one of two parental types
(open circles or triangles). The growing ¢bril of a given conforma-
tion, however, only accepts the addition of parental prions of the
same conformation. B: Shows the ‘deterministic selection’ model.
The original population of prions is supposed to exist as a persis-
tently heterogeneous ensemble of conformations (either due to in-
trinsic properties of the prion molecule or to stabilization of di¡er-
ent conformers by interaction with di¡erent modulators; see text).
Fibril growth and strain propagation, thus, involve selection of the
‘appropriate’ conformer from the solution.
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in vitro by AL peptides of di¡erent chain-lengths were inves-
tigated in denaturant solutions. We found that the stability of
AL ¢brils in guanidine hydrochloride solutions was markedly
increased when the peptide contained a cluster of non-polar
amino acids (residues 29^42) in its C-terminal region. Further-
more, cooling caused reversible and nearly complete disaggre-
gation of AL ¢brils, suggesting that a signi¢cant contribution
to the stability of AL ¢brils comes from entropy-driven hydro-
phobic interactions (which are known to be destabilized at
low temperatures). These observations led to the hypothesis
that hydrophobic compounds could be e¡ective in destabiliz-
ing and disaggregating amyloid ¢brils.
After examining a number of moderately hydrophobic com-
pounds (i.e. su⁄ciently hydrophobic to interfere with amyloid
aggregation but still maintaining good solubility in aqueous
media), we found that nitrophenols (e.g. 2,4-dinitrophenol,
DNP, or 3-nitrophenol, NP) prevent amyloid aggregation in
vitro and cause the disassembly of pre-aggregated ¢brils [45].
Of greater interest, nitrophenols block the neurotoxicity of AL
to rat hippocampal neurons in primary culture, and cause a
marked reduction in the area occupied by amyloid deposits in
rat brains [45]. These results indicate that nitrophenols and
their derivatives should be explored as possible drug candi-
dates or lead compounds for the development of drugs to
prevent amyloid aggregation and neurotoxicity in AD.
6. Conclusions
The notion that proteins exist as ensembles of molecules in
di¡erent conformational substates explains the origin of fast
intramolecular protein motions [17]. Furthermore, it may be
generally expanded to explain apparently ‘anomalous’ pro-
tein^protein interactions in oligomeric assemblies, provided
that activation barriers of the appropriate magnitude are con-
sidered for interconversion between di¡erent conformational
substates [10]. The deterministic behavior of protein ensem-
bles caused by high free-energy barriers for conformational
interconversion may be directly related to strain formation
in prion diseases and to amyloid aggregation in other amyloi-
dosis.
A problem shared by all in vitro studies of amyloidogenesis
is that the in vitro environment probably does not reproduce
the in vivo milieu. Conceivably, amyloidogenic proteins inter-
act in vivo with a number of intracellular or extracellular
‘modulators’ (e.g. other proteins, glycosaminoglicans) that
shift the equilibrium of conformations towards conformers
that are more or less amyloidogenic. Ageing, which normally
favors the manifestation of amyloid diseases, may cause
changes in the availability of such modulators that eventually
lead to stabilization of amyloid-prone conformers. Such mod-
ulators may also cause changes in activation free-energy bar-
riers between states, leading to changes in the rates of con-
formational interconversion. In this context, it is important to
consider that the ‘induced conformational change’ model for
amyloid formation proposed on the basis of extensive in vitro
studies has yet to be proved for amyloidogenesis in vivo. As
an alternative hypothesis, one should consider that di¡erent
conformational substates of a potentially amyloidogenic pro-
tein may be kinetically or thermodynamically stabilized in
vivo by interactions with di¡erent types of modulators exhib-
iting distinct a⁄nities for di¡erent conformational states of
the protein. This would lead to a deterministic scenario in
which amyloid formation could be viewed as a slow process
of selection and aggregation of the amyloidogenic conforma-
tion amongst all possible existing conformers.
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